The Department of Veterans Affairs is seeking interest from potential contractors for the supply of domestically manufactured pharmaceuticals for the Consolidated Mail Outpatient Pharmacy (CMOP) program, as outlined in the Sources Sought Notice 36C77025Q0183. The VA is specifically looking for responses from both small and large pharmaceutical manufacturers and distributors capable of providing a specified list of medications, including Galantamine Hydrobromide and Hydrocortisone Ointment, among others. This initiative is crucial for ensuring a reliable pharmaceutical supply chain for veterans’ healthcare, aligning with Federal Acquisition Regulations to foster early dialogue about acquisitions. Interested parties must submit their responses to Sarah Fry at sarah.fry2@va.gov by March 18, 2025, as this is an information-gathering activity without any contractual obligations.